Skip to main content

Relapse in Kala Azar: Failure of Sodium Stibogluconate to Clear Parasites from Organs Other than the Liver

  • Chapter
Leishmaniasis

Part of the book series: NATO ASI Series ((NSSA,volume 171))

  • 28 Accesses

Abstract

Relapse in Kala-azar is a common problem, occurring in 5–30% of patients (Chulay et al, 1983, Sanyal and Arora, 1979). Although this could be attributed to re-infection, there is a strong possibility that it may at least partly be due to treatment failure. Two recent studies suggest that removal of parasites from certain tissue sites may be difficult.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adinolfi, L.E., Bonventre, P.F., Vander Pas, M. and Eppstein, D.A. (1985) Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis. Infect. and Immun., 48:409.

    CAS  Google Scholar 

  • Alving, C.R. (1986) Liposomes as drug carriers in leishmaniasis and malaria. Parasit. Today, 2:101.

    Article  CAS  Google Scholar 

  • Anabwani, G.M., Ngira, J.A., Dimiti, G. and Bryceson, A.D.M. (1983) Comparison of two dosage schedules of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. Lancet, 29 July, 1983, 211.

    Google Scholar 

  • Baillie, A.J., Florence, A.T., Hume, L.R., Muirhead, G.T. and Rogerson, A. (1985) The preparation and properties of niosomes — non-ionic surfactant vesicles. J. Pharm.Pharmacol., 37:863.

    Article  PubMed  CAS  Google Scholar 

  • Baillie, A.J., Coombs, G.H., Dolan, T.F. and Laurie, J. (1986) Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-1eishmanial drug, sodium stibogluconate. J.Pharm.Pharmacol., 38:502.

    Article  PubMed  CAS  Google Scholar 

  • Black, C.D.V., Watson, G.J. and Ward, R.J. (1977) The use of pentostam liposomes in the chemotherapy of experimental leishmaniasis. Trans.Royal Soc.Trop.Med.Hyg., 71:550.

    Article  CAS  Google Scholar 

  • Blackwell, J.M., Freeman, J.C. and Bradley D.J. (1980) Influence of the H-2 complex on acquired resistance to Leishmania donovani infection in mice. Nature, 283:72.

    Article  PubMed  CAS  Google Scholar 

  • Bradley, D.J. and Kirkley, J. (1977) Regulation of Leishmania populations within the host. 1. The variable course of Leishmania donovani infections in mice. Clin.Exp.Immunol., 30:119.

    PubMed  CAS  Google Scholar 

  • Carter, K.C., Baillie, A.J., Alexander, J. and Dolan, T.F. (1987) submitted J. Pharm.Pharmacol. The therapeutic effect of sodium stibogluconate in BALB/c mice infected with L. donovani is organ dependent.

    Google Scholar 

  • Chulay, J.D., Bhatt, S.M., Muigai, R., Ho, M., Gochihi, G., Were, J.B., Chunge, C. and Bryceson, A.D. (1983) A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. J. Infect. Dis., 148:148.

    Article  PubMed  CAS  Google Scholar 

  • Koech, D.K. (1987) Subpopulations of T. lymphocytes in Kenyan patients with visceral leishmaniasis. Am.J.Trop.Med.Hyg., 36:497.

    PubMed  CAS  Google Scholar 

  • Manson-Bahr, P.E.C. (1959) East African kala-azar with special reference to the pathology, prophylaxis and treatment. Trans.Roy.Soc.Trop.Med.Hyg., 53:123.

    Article  PubMed  CAS  Google Scholar 

  • Napier, L.E. (1946) in “The Principles and Practice of Tropical Medicine”, p.134, Macmillan, New York.

    Google Scholar 

  • Sacks, D.L., Lai, S.L., Shrivastava, S.N., Blackwell, J. and Neva, F.A. (1987) An analysis of T cell responsiveness in Indian Kala-azar. J.Immunol., 138:908.

    PubMed  CAS  Google Scholar 

  • Sanyal, R.K. and Arora, R.R. (1979) Assessment of drug therapy of Kala-azar in current epidemic in Bihar.J.Commun.Dis., 11:198.

    Google Scholar 

  • Ulczak, O.M. and Blackwell, J.M. (1983) Immunoregulation of genetically controlled acquired response to Leishmania donovani. Infection if mice: the effects of parasite dose, cyclophosphamide and sublethal irradiation. Parasite Immunol., 5:449.

    Article  PubMed  CAS  Google Scholar 

  • Wickramasinghe, S.N., Abdalla, S.H. and Kaisili, E.G. (1987) Ultrastructure of bone marrow in patients with visceral leishmaniasis. J.Clin.Path., 40:267.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer Science+Business Media New York

About this chapter

Cite this chapter

Carter, K.C., Alexander, J., Baillie, A.J., Dolan, T.F. (1989). Relapse in Kala Azar: Failure of Sodium Stibogluconate to Clear Parasites from Organs Other than the Liver. In: Hart, D.T. (eds) Leishmaniasis. NATO ASI Series, vol 171. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1575-9_89

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1575-9_89

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8862-6

  • Online ISBN: 978-1-4613-1575-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics